Allison Brashear. (2003). Use of botulinum toxin type A in poststroke spasticity. Expert Review of Neurotherapeutics, 3(3), 271–277. https://doi.org/10.1586/14737175.3.3.271
Areerat Suputtitada, Supattana Chatromyen, Carl P. C. Chen, & David M. Simpson. (2024). Best Practice Guidelines for the Management of Patients with Post-stroke Spasticity: A Modified Scoping Review. Toxins. https://doi.org/10.3390/toxins16020098
Cai, Y., Zhang, C. S., Ouyang, W., Li, J., Nong, W., Zhang, A. L., Xue, C. C., & Wen, Z. (2018). Electroacupuncture for poststroke spasticity (EAPSS): Protocol for a randomised controlled trial. BMJ Open, 8(2), 1–9. https://doi.org/10.1136/BMJOPEN-2017-017912
Cousins, E., Ward, A., Roffe, C., Rimington, L. D., & Pandyan, A. (2009). Quantitative Measurement of Poststroke Spasticity and Response to Treatment With Botulinum Toxin: A 2-Patient Case Report. Physical Therapy, 89(7), 688–697. https://doi.org/10.2522/PTJ.20080040
Lagalla, M. Danni, Frank Reiter, Maria Gabriella Ceravolo, & Leandro Provinciali. (2000). Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. American Journal of Physical Medicine & Rehabilitation, 79(4), 377–384. https://doi.org/10.1097/00002060-200007000-00010
Geoffrey Sheean. (2008). Botulinum toxin should be first-line treatment for poststroke spasticity. Journal of Neurology, Neurosurgery, and Psychiatry, 80(4), 359–359. https://doi.org/10.1136/JNNP.2008.164889
John R. McGuire. (2001). Effective use of chemodenervation and chemical neurolysis in the management of poststroke spasticity. Topics in Stroke Rehabilitation, 8(1), 47–55. https://doi.org/10.1310/CYP4-BPXC-CG8M-XCA3
Kaku, M., & Simpson, D. M. (2016). Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity. Drug Design Development and Therapy, 10, 1085–1099. https://doi.org/10.2147/DDDT.S80804
Katoozian, L., Tahan, N., Zoghi, M., & Bakhshayesh, B. (2018). The Onset and Frequency of Spasticity After First Ever Stroke. Journal of The National Medical Association, 110(6), 547–552. https://doi.org/10.1016/J.JNMA.2018.01.008
Lackritz, H., Parmet, Y., Frenkel-Toledo, S., Baniña, M. C., Soroker, N., Solomon, J. M., Liebermann, D. G., Levin, M. F., & Berman, S. (2021). Effect of post-stroke spasticity on voluntary movement of the upper limb. Journal of Neuroengineering and Rehabilitation, 18(1), 81–81. https://doi.org/10.1186/S12984-021-00876-6
Li, S., Li, S., Francisco, G. E., Francisco, G. E., & Rymer, W. Z. (2021). A New Definition of Poststroke Spasticity and the Interference of Spasticity With Motor Recovery From Acute to Chronic Stages. Neurorehabilitation and Neural Repair, 35(7), 601–610. https://doi.org/10.1177/15459683211011214
Lindsey Kerr, Vanessa D. Jewell, & Lou Jensen. (2020). Stretching and splinting interventions for poststroke spasticity, hand function, and functional tasks: A systematic review. American Journal of Occupational Therapy, 74(5), 029454. https://doi.org/10.5014/AJOT.2020.029454
Marano, M., Suppa, A., Palmieri, M. G., Cecconi, E., Frisullo, G., Bovenzi, R., Riso, V., Anzini, A., Brienza, M., Anticoli, S., Crupi, D., Giovannelli, M., Massimiani, A., Rinalduzzi, S., Morena, E., Massara, M., Cupini, L. M., Bressi, F., Pilato, F., … Cotelli, M. S. (2024). Comprehensive Observational and Longitudinal study on the Outbreak of Stroke-related Spasticity focusing on the Early Onset management with Botulinum NeuroToxin (COLOSSEO-BoNT): Protocol for a real-world prospective observational study on upper limb spasticity. BMJ Open, 14(6), e085484–e085484. https://doi.org/10.1136/bmjopen-2024-085484
McIntyre, A., Teasell, R., Saikaley, M., & Miller, T. (2024). Predictors of Spasticity 3-6 Months Post Stroke: A 5-Year Retrospective Cohort Study. American Journal of Physical Medicine & Rehabilitation. https://doi.org/10.1097/phm.0000000000002496
Opara, J., Taradaj, J., Walewicz, K., Rosińczuk, J., & Dymarek, R. (2021). The Current State of Knowledge on the Clinical and Methodological Aspects of Extracorporeal Shock Waves Therapy in the Management of Post-Stroke Spasticity-Overview of 20 Years of Experiences. Journal of Clinical Medicine, 10(2). https://doi.org/10.3390/JCM10020261
Shaw, L., & Rodgers, H. (2009). Botulinum toxin type A for upper limb spasticity after stroke. Expert Review of Neurotherapeutics, 9(12), 1713–1725. https://doi.org/10.1586/ERN.09.121
Shiner, C. T., Shiner, C. T., Vratsistas-Curto, A., Bramah, V., Faux, S. G., Faux, S. G., & Watanabe, Y. (2020). Prevalence of upper-limb spasticity and its impact on care among nursing home residents with prior stroke. Disability and Rehabilitation, 42(15), 2170–2177. https://doi.org/10.1080/09638288.2018.1555620
Starosta, M., Marek, K., Redlicka, J., & Miller, E. (2024). Extracorporeal Shockwave Treatment as Additional Therapy in Patients with Post-Stroke Spasticity of Upper Limb—A Narrative Review. Journal of Clinical Medicine. https://doi.org/10.3390/jcm13072017
Ward, A. B. (2012). A literature review of the pathophysiology and onset of post-stroke spasticity. European Journal of Neurology, 19(1), 21–27. https://doi.org/10.1111/J.1468-1331.2011.03448.X
Zorowitz, R. D., Gillard, P., & Brainin, M. (2013). Poststroke spasticity Sequelae and burden on stroke survivors and caregivers. Neurology, 80. https://doi.org/10.1212/WNL.0B013E3182764C86
參考資料